Circulating Tumour DNA guidEd Therapy for Stage IIB/C mElanoma After surgiCal resecTION

Clinical trial NCT04901988 · TERMINATED

Trial details

NCT number: NCT04901988
Sponsor: The Christie NHS Foundation Trust
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Melanoma (Skin)Melanoma, Stage II

Start date: 2021-11-08
Primary completion: 2023-01-30
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.